Combining GLP-1 Drugs With Other Therapies Synergistically Reduces Alcohol Intake
Combined pharmacotherapy including GLP-1 drugs produced synergistic-like decreases in alcohol intake, supporting multi-target approaches to alcohol use disorder.
Quick Facts
What This Study Found
Combined pharmacotherapy including GLP-1 drugs produced synergistic-like decreases in alcohol intake, supporting multi-target approaches to alcohol use disorder.
Key Numbers
Synergistic-like effect observed — combined drug effect exceeded the expected additive effect of individual treatments.
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide evidence.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Evidence comparison?
- ?Next steps?
Trust & Context
- Key Stat:
- Key finding Combined pharmacotherapy including GLP-1 drugs produced synergistic-like decreases in alcohol intake
- Evidence Grade:
- Based on design.
- Study Age:
- Published in 2025.
- Original Title:
- Synergistic-like decreases in alcohol intake following combined pharmacotherapy with GLP-1 and amylin in male rats.
- Published In:
- British journal of pharmacology, 182(6), 1292-1305 (2025)
- Authors:
- Aranäs, Cajsa(4), Caffrey, Antonia(3), Edvardsson, Christian E(6), Vestlund, Jesper, Schmidt, Heath D, Jerlhag, Elisabet
- Database ID:
- RPEP-09967
Evidence Hierarchy
Frequently Asked Questions
What does this mean?
Combined pharmacotherapy including GLP-1 drugs produced synergistic-like decreases in alcohol intake, supporting multi-target approaches to alcohol use disorder.
How reliable?
Consult publication.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09967APA
Aranäs, Cajsa; Caffrey, Antonia; Edvardsson, Christian E; Vestlund, Jesper; Schmidt, Heath D; Jerlhag, Elisabet. (2025). Synergistic-like decreases in alcohol intake following combined pharmacotherapy with GLP-1 and amylin in male rats.. British journal of pharmacology, 182(6), 1292-1305. https://doi.org/10.1111/bph.17406
MLA
Aranäs, Cajsa, et al. "Synergistic-like decreases in alcohol intake following combined pharmacotherapy with GLP-1 and amylin in male rats.." British journal of pharmacology, 2025. https://doi.org/10.1111/bph.17406
RethinkPeptides
RethinkPeptides Research Database. "Synergistic-like decreases in alcohol intake following combi..." RPEP-09967. Retrieved from https://rethinkpeptides.com/research/aranas-2025-synergisticlike-decreases-in-alcohol
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.